{
    "name": "pancrelipase",
    "comment": "Rx",
    "other_names": [
        "Creon",
        "Pancreaze",
        "Pertzye",
        "Ultresa",
        "Viokace",
        "Zenpep"
    ],
    "classes": [
        "Pancreatic/Digestive Enzymes"
    ],
    "source": "https://reference.medscape.com/drug/creon-pancreaze-pancrelipase-342069",
    "pregnancy": {
        "common": [
            "Pregnancy Category: C",
            "Lactation: unknown"
        ],
        "specific": []
    },
    "lactation": {
        "common": [
            "Lactation: unknown"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "Documented hypersensitivity"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Avoid exceeding maximum dose due to risk of fibrosing colonopathy; ≥6,000 lipase units/kg per meal associated with colonic stricture, indicative of fibrosing colonopathy, particularly in children ≤12 years",
                "Swallow pills as chewing or retaining in mouth may cause oral mucosa irritation; do not chew, crush or mixed in foods having a pH ≥4.5",
                "Monitor uric acid levels in patients with gout, hyperuricemia or renal impairment due to risk of hyperuricemia",
                "Caution in patients with known allergy or porcine proteins",
                "Do not exceed ≥2,500 units/kg per meal (or ≥10,000 lipase units/kg per day or ≥ 4000 lipase units/g fat ingested per day)",
                "Avoid inhalation of powder",
                "Theoretical risk of viral transmission"
            ],
            "specific": []
        }
    },
    "interactions": [
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "acarbose",
            "description": {
                "common": "pancrelipase decreases effects of acarbose by pharmacodynamic antagonism. Use Caution/Monitor. Antihyperglycemic action of acarbose results from a competitive, reversible inhibition of pancreatic alpha-amylase and membrane-bound intestinal alpha-glucoside hydrolase enzymes."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "calcium carbonate",
            "description": {
                "common": "calcium carbonate decreases effects of pancrelipase by pharmacodynamic antagonism. Use Caution/Monitor. Antacids may negate beneficial effects of enzymes."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "ferric maltol",
            "description": {
                "common": "pancrelipase decreases levels of ferric maltol by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor. Levels of iron salts may decrease with concomitant administration of digestive enzymes."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "ferrous fumarate",
            "description": {
                "common": "pancrelipase decreases levels of ferrous fumarate by enhancing GI absorption. Applies only to oral form of both agents. Use Caution/Monitor. Levels of iron salts may decrease with concomitant administration of digestive enzymes."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "ferrous gluconate",
            "description": {
                "common": "pancrelipase decreases levels of ferrous gluconate by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor. Levels of iron salts may decrease with concomitant administration of digestive enzymes."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "ferrous sulfate",
            "description": {
                "common": "pancrelipase decreases levels of ferrous sulfate by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor. Levels of iron salts may decrease with concomitant administration of digestive enzymes."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "folic acid",
            "description": {
                "common": "pancrelipase decreases levels of folic acid by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor. folic deficiency may occur."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "magnesium hydroxide",
            "description": {
                "common": "magnesium hydroxide decreases effects of pancrelipase by pharmacodynamic antagonism. Use Caution/Monitor. Antacids may negate beneficial effects of enzymes."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "miglitol",
            "description": {
                "common": "pancrelipase decreases levels of miglitol by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor. Digestive enzymes may reduce levels of miglitol when administered concomitantly."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "polysaccharide iron",
            "description": {
                "common": "pancrelipase decreases levels of polysaccharide iron by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor. Levels of iron salts may decrease with concomitant administration of digestive enzymes."
            }
        }
    ],
    "adverse effects": [
        {
            "name": "Abdominal pain",
            "percent": "3-18"
        },
        {
            "name": "cramping",
            "percent": "3-15"
        },
        {
            "name": "Headache",
            "percent": "10"
        },
        {
            "name": "Dyspepsia",
            "percent": "4-10"
        },
        {
            "name": "Cough",
            "percent": "0-10"
        },
        {
            "name": "Diarrhea",
            "percent": "8"
        },
        {
            "name": "Hyperglycemia",
            "percent": "7"
        },
        {
            "name": "Pharyngolaryngeal pain",
            "percent": "7"
        },
        {
            "name": "Epistaxis",
            "percent": "7"
        },
        {
            "name": "Anal pruritus",
            "percent": "7"
        },
        {
            "name": "Biliary tract stones",
            "percent": "6"
        },
        {
            "name": "Vomiting",
            "percent": "6"
        },
        {
            "name": "Contusion",
            "percent": "6"
        },
        {
            "name": "Weight loss",
            "percent": "6"
        },
        {
            "name": "Early satiety",
            "percent": "5-6"
        },
        {
            "name": "Flatulence",
            "percent": "4"
        },
        {
            "name": "Dizziness",
            "percent": "4"
        },
        {
            "name": "Hypoglycemia",
            "percent": "4"
        },
        {
            "name": "Abnormal feces",
            "percent": "4"
        },
        {
            "name": "Frequent bowel movements",
            "percent": "4"
        },
        {
            "name": "Nasopharyngitis",
            "percent": "3"
        },
        {
            "name": "Anemia",
            "percent": "3"
        },
        {
            "name": "Ascites",
            "percent": "3"
        },
        {
            "name": "Flatulence",
            "percent": "3"
        },
        {
            "name": "Peripheral edema",
            "percent": "3"
        },
        {
            "name": "Hydrocholecystis",
            "percent": "3"
        },
        {
            "name": "Viral infection",
            "percent": "3"
        },
        {
            "name": "Renal cyst",
            "percent": "3"
        },
        {
            "name": "Rash",
            "percent": null
        },
        {
            "name": "Severe allergic reactions including anaphylaxis",
            "percent": null
        },
        {
            "name": "asthma and hives",
            "percent": null
        },
        {
            "name": "Skin disorders including pruritus",
            "percent": null
        },
        {
            "name": "rash and urticaria",
            "percent": null
        },
        {
            "name": "Asymptomatic elevations of liver enzymes",
            "percent": null
        },
        {
            "name": "Gastrointestinal disorders",
            "percent": null
        },
        {
            "name": "Abdominal distension",
            "percent": null
        },
        {
            "name": "abdominal pain",
            "percent": null
        },
        {
            "name": "diarrhea",
            "percent": null
        },
        {
            "name": "flatulence",
            "percent": null
        },
        {
            "name": "constipation and nausea",
            "percent": null
        },
        {
            "name": "rare reports of fibrosing colonopathy and distal intestinal obstruction syndrome",
            "percent": null
        },
        {
            "name": "Endocrine",
            "percent": null
        },
        {
            "name": "May affect glycemic control in susceptible individuals",
            "percent": null
        }
    ]
}